Nixon Peabody Trust Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.39M |
| 2 |
General Dynamics
GD
|
+$1.11M |
| 3 |
Mastercard
MA
|
+$982K |
| 4 |
Waste Management
WM
|
+$916K |
| 5 |
Amazon
AMZN
|
+$895K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$989K |
| 2 |
Johnson & Johnson
JNJ
|
+$726K |
| 3 |
Automatic Data Processing
ADP
|
+$450K |
| 4 |
Cisco
CSCO
|
+$420K |
| 5 |
ExxonMobil
XOM
|
+$326K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.16% |
| 2 | Healthcare | 14.04% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Consumer Staples | 9.67% |
Similar funds
Nixon Peabody Trust's Q1 2019 Portfolio in Review
As of Q1 2019, Nixon Peabody Trust held 74 positions worth $153M, up 20% from $127M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Nixon Peabody Trust deployed $10.5M of net new capital in Q1 2019, opening 4 new positions and adding to 37 existing holdings. Its largest new stake was Pioneer Natural Resource Co.: 9,815 shares worth $1.49M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $989K trimmed.
- Nixon Peabody Trust's largest Q1 2019 buy was Pioneer Natural Resource Co.: 9,815 shares worth $1.49M.
- Nixon Peabody Trust added most to General Dynamics in Q1 2019, an estimated $1.11M increase.
- Nixon Peabody Trust's biggest Q1 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $989K.
- Nixon Peabody Trust fully exited Pfizer in Q1 2019, selling an estimated $214K.
- Nixon Peabody Trust's ten largest holdings make up 30% of its $153M portfolio in Q1 2019.
- Nixon Peabody Trust opened 4 new positions and closed 1 in Q1 2019.
- Nixon Peabody Trust's portfolio value rose 20% quarter-over-quarter to $153M.
Based on Nixon Peabody Trust's 13F filing for Q1 2019, filed 19 Apr 2019.